| Project/Area Number |
16590008
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Chemical pharmacy
|
|---|
| Research Institution | Toyama Prefectural University |
|---|
Principal Investigator |
NAKAJIMA Noriyuki Toyama Prefectural University, Faculty of Engineering, Department of Biochemistry, Professor, 工学部, 教授 (40188959)
|
|---|
| Project Period (FY) |
2004 – 2006
|
| Project Status |
Completed (Fiscal Year 2006)
|
| Budget Amount *help |
¥3,700,000 (Direct Cost: ¥3,700,000)
Fiscal Year 2006: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 2005: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 2004: ¥2,600,000 (Direct Cost: ¥2,600,000)
|
|---|
| Keywords | nucleoside antibiotics / peptidoglycan / biosynthesis inhibitor / total synthesis / diazepanone ring / nitrobenzenesulfonamide protecting group / 構造活性相関 |
|---|
| Research Abstract |
Liposidomycins are a family of novel lipid-containing nucleoside antibiotics of unusual complexity, found in the culture filtrate and mycelia of streptomyces griseosporeus. They are selective antibiotics showing highly specific inhibition toward phospho-N-acetylmuramylpentapeptide transferase that is the primary stage of a lipid cycle in bacterial peptidoglycan synthesis. Liposidomycin B also inhibits in vitro formation of polyprenyl(pyro)phosphate N-acetylglucosamine, an intermediate in glycoconjugate biosynthesis. The structures were proposed on the basis of NMR and mass spectral evidence of degradation compound but the stereochemistry was revealed by X-ray crystallography analysis of caprazamycin that is an analog of liposidomycins.
We start to study the synthetic of liposidomycin degradation product. A stereocontrolled synthesis of the liposidomycin diazepanone ring system having a phenyl substituent has been achieved. In the presence of an amino group on the diazepanone ring, the introduction of a uracil group did failed. The N-glycosylation proceeded smoothly to obtain the uracil compound having electron-withdrawing nitrobenzenesulfonamide (Ns) and formyl protecting at an amino group on the diazepanone ring. The detailed examination of the N-glycosylation was accomplished for the total synthesis of liposidomycins.
|
